Clinical Trial: Singapore - Malaysia - Shanghai Kidney Trial - Nephrotic Syndrome (SMART-NS): Dulepivoumab for maintenance treatment of steroid-dependent and frequently relapsing nephrotic syndrome (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Singapore - Malaysia - Shanghai Kidney Trial - Nephrotic Syndrome (SMART-NS): Dulepivoumab for maintenance treatment of steroid-dependent and frequently relapsing nephrotic syndrome'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130430

Registration Time: 2026/08/19

Type: Interventional study

Primary Sponsor: Children's Hospital of Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337513

Published by HT Digital Content Services with permission from Health Daily Digest....